Delivery Order SPE2DB22D2206-SPE2DB26FDR84
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30, with a ceiling value of $2,347.10. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $3,148.80. This firm fixed-price delivery order is not set-aside and represents performance work to be completed by the ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 10, with a contract ceiling value of $1,688.16. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract value of $2,590.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30 count) with a ceiling value of $1,835.95, effective August 19, 2025, with ultimate completion by August 20, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,107.60 for Isotretinoin 30 mg capsules (30-count units) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract to be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a ceiling value of $1,978.20. This delivery order utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units, with a contract ceiling value of $17,955.69. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded without a set-aside designation, indicating it was awarded through open competition. The contract is executed from AmerisourceBergen's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDR84Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order valued at $8,552.77, with an ultimate completion date of October 21, 2025. The contract is a non-set-aside award, meaning it was competitively awarded without preference restrictions. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, which serves as the company's corporate office. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a significant prime IDC valued at $999,999,999.00 through December 2026 that serves as the overarching contract vehicle for this pharmaceutical delivery. The company's federal contract portfolio demonstrates extensive experience supplying critical medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. Isotretinoin, a prescription retinoid medication primarily used for severe acne treatment, falls within the specialized pharmaceutical commodities the company routinely delivers through its DLA contract relationships to support Defense Health Agency operations and broader federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 10/20/25 |